Skin cancer is a global health challenge, with nearly 1.5 million new cases diagnosed in 2024, according to World Health Organization (WHO) data. In response, the University of Alicante (UA) and the Sant Joan d'Alacant University Hospital have collaborated to launch MEL-IA (MobilE skin Lesion dIAgnosis), an artificial intelligence system designed to automate the classification of skin lesions.
AI Tool MEL-IA Launched to Enhance Skin Cancer Diagnosis
The University of Alicante and Sant Joan d'Alacant University Hospital have developed MEL-IA, an AI system for classifying skin lesions, addressing the global challenge of skin cancer. This initiative highlights advancements in healthcare technology that could be relevant for Iran's medical sector. The integration of AI in healthcare could improve diagnostic capabilities in Iran, where skin cancer is a growing concern.
👥 Key Players
📰 What Happened
The University of Alicante and Sant Joan d'Alacant University Hospital launched MEL-IA, an AI system aimed at automating the classification of skin lesions to combat skin cancer.
- Nearly 1.5 million new skin cancer cases are expected to be diagnosed globally in 2024.
- MEL-IA aims to enhance diagnostic accuracy and efficiency in identifying skin lesions.
💡 Why It Matters
📚 Background
Skin cancer is a major health issue worldwide, and advancements in AI technology offer new methods for early detection and treatment.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%